Oral / IV
    Weekly dosing
    • Mechanism of Action
    • Inflammatory diseases: inhibits interleukin-1 and interleukin 6 activity, and altering the numbers of different lymphocyte subsets.
      In cancer treatment: inhibits dihydrofolate reductase (DHFR), reducing synthesis of folate, which is involved in synthesis of the purine and pyramidine precursors required for DNA / RNA and cell proliferation.
    • Pharmacology
    • Serum half-life 8 hours
    • Renal excretion - caution in combination with NSAIDs

Clinical Use

    • Indications
    • Inflammatory diseases - refractory inflammatory bowel disease, rheumatoid arthritis, psoriasis
    • Chemotherapy - for certain cancers
    • Adverse Effects
    • Gastrointestinal - mouth ulcers, nausea / vomiting / abdominal pain
    • Hepatotoxicity - elevated LFTs, cirrhosis
    • Pulmonary - hypersensitivity pneumonitis
    • Bone marrow suppression - leukopaenia / thrombocytopaenia / anaemia
    • Monitoring
    • Monthly full blood count, renal function and LFTs.
Want more info like this?
  • Your electronic clinical medicine handbook
  • Guides to help pass your exams
  • Tools every medical student needs
  • Quick diagrams to have the answers, fast
  • Quizzes to test your knowledge